Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GreenLight Biosciences

    NASDAQ: GRNA · Real-Time Price · USD
    0.30
    0.00 (0.13%)
    At close: Jul 21, 2023, 10:00 PM

    GreenLight Biosciences Statistics

    Share Statistics

    GreenLight Biosciences has 151.68M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 151.68M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 29,650

    FTD / Avg. Volume

    n/a
    		 4.33%

    Short Selling Information

    The latest short interest is 901.46K, so 0.59% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 901.46K

    Short % of Shares Out

    n/a
    		 0.59%

    Short % of Float

    n/a
    		 0.96%

    Short Ratio (days to cover)

    n/a
    		 4.71

    Valuation Ratios

    The PE ratio is -0.93 and the forward PE ratio is null. GreenLight Biosciences's PEG ratio is -0.03.

    PE Ratio

    n/a
    		 -0.93

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 24.39

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 3.24

    P/FCF Ratio

    n/a
    		 -0.95

    PEG Ratio

    n/a
    		 -0.03
    Financial Ratio History

    Enterprise Valuation

    GreenLight Biosciences has an Enterprise Value (EV) of 168.12M.

    EV / Sales

    n/a
    		 26.33

    EV / EBITDA

    n/a
    		 -1.09

    EV / EBIT

    n/a
    		 -1.23

    EV / FCF

    n/a
    		 -1.03

    Financial Position

    The company has a current ratio of 2.01, with a Debt / Equity ratio of 1.67.

    Current Ratio

    n/a
    		 2.01

    Quick Ratio

    n/a
    		 2.01

    Debt / Equity

    n/a
    		 1.67

    Debt / EBITDA

    n/a
    		 -0.52

    Debt / FCF

    n/a
    		 -0.49

    Interest Coverage

    n/a
    		 -39.76

    Financial Efficiency

    Return on Equity is -347.58% and Return on Invested Capital is -128.36%.

    Return on Equity

    n/a
    		 -347.58%

    Return on Assets

    n/a
    		 -112.42%

    Return on Invested Capital

    n/a
    		 -128.36%

    Revenue Per Employee

    n/a
    		 $22,800

    Profits Per Employee

    n/a
    		 $-596,625

    Employee Count

    n/a
    		 280

    Asset Turnover

    n/a
    		 0.04

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.09M

    Effective Tax Rate

    n/a
    		 -0.66%

    Stock Price Statistics

    The stock price has increased by 0.17% in the last 52 weeks. The beta is 1.44, so GreenLight Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.44

    52-Week Price Change

    n/a
    		 0.17%

    50-Day Moving Average

    n/a
    		 0.27

    200-Day Moving Average

    n/a
    		 0.85

    Relative Strength Index (RSI)

    n/a
    		 59

    Average Volume (20 Days)

    n/a
    		 684,804

    Income Statement

    In the last 12 months, GreenLight Biosciences had revenue of 6.38M and earned -167.06M in profits. Earnings per share was -1.27.

    Revenue

    n/a
    		 6.38M

    Gross Profit

    n/a
    		 6.38M

    Operating Income

    n/a
    		 -163.92M

    Net Income

    n/a
    		 -167.06M

    EBITDA

    n/a
    		 -153.99M

    EBIT

    n/a
    		 -161.84M

    Earnings Per Share (EPS)

    n/a
    		 -1.27
    Full Income Statement

    Balance Sheet

    The company has 68.1M in cash and 80.48M in debt, giving a net cash position of -12.38M.

    Cash & Cash Equivalents

    n/a
    		 68.1M

    Total Debt

    n/a
    		 80.48M

    Net Cash

    n/a
    		 -12.38M

    Retained Earnings

    n/a
    		 -420.64M

    Total Assets

    n/a
    		 113.69M

    Working Capital

    n/a
    		 6.51M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -136.73M and capital expenditures -26.55M, giving a free cash flow of -163.28M.

    Operating Cash Flow

    n/a
    		 -136.73M

    Capital Expenditures

    n/a
    		 -26.55M

    Free Cash Flow

    n/a
    		 -163.28M

    FCF Per Share

    n/a
    		 -1.24
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -2567.65% and -2616.78%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -2567.65%

    Pretax Margin

    n/a
    		 -2599.67%

    Profit Margin

    n/a
    		 -2616.78%

    EBITDA Margin

    n/a
    		 -2412.11%

    EBIT Margin

    n/a
    		 -2567.65%

    FCF Margin

    n/a
    		 -2557.61%

    Dividends & Yields

    GRNA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -107.27%

    FCF Yield

    n/a
    		 -104.85%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for GRNA.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.59

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist